# ASCVD Algorithm Test Analysis
**Critical Validation Findings - All Test Cases Failed**

## 🚨 CRITICAL ISSUES IDENTIFIED

### Test Results Summary
**ALL 6 TEST CASES FAILED** - Algorithm produces systematic deviations from expected medical values

| Test Case | Expected | Calculated | Deviation | Status |
|-----------|----------|------------|-----------|---------|
| 1: White Male | 7.5% | 10.0% | +2.5% | FAIL ❌ |
| 2: AA Female | 22.3% | 39.9% | +17.6% | FAIL ❌ |
| 3: White Female | 2.1% | 0.4% | -1.7% | FAIL ❌ |
| 4: AA Male | 35.8% | 56.2% | +20.4% | FAIL ❌ |
| 5: White Male | 6.2% | 5.3% | -0.9% | FAIL ❌ |
| 6: White Female | 8.9% | 6.4% | -2.5% | FAIL ❌ |

## 🔍 PATTERN ANALYSIS

### Systematic Deviations
1. **African American calculations significantly OVERESTIMATE risk** (Test 2: +17.6%, Test 4: +20.4%)
2. **White Female calculations consistently UNDERESTIMATE risk** (Test 3: -1.7%, Test 6: -2.5%)
3. **White Male results show mixed patterns** (Test 1: +2.5%, Test 5: -0.9%)

### Potential Root Causes

#### 1. Coefficient Source Verification Needed
- **Issue**: Coefficients may not match official ACC/AHA specifications
- **Evidence**: Systematic deviations across all demographic groups
- **Action**: Cross-validate against original Goff et al. paper

#### 2. Baseline Survival (S₀₁₀) Values
- **Issue**: S₀₁₀ values might be incorrect or from different cohort
- **Evidence**: Consistent over/under-estimation patterns by race/sex
- **Action**: Verify baseline survival probabilities

#### 3. Mean Coefficient Centering
- **Issue**: Mean coefficient sums may be incorrect
- **Evidence**: Risk calculations systematically off
- **Action**: Validate mean centering values

#### 4. Mathematical Implementation
- **Issue**: Formula implementation might have subtle errors
- **Evidence**: Consistent but varying deviations
- **Action**: Review Cox proportional hazards calculation

## 🎯 IMMEDIATE ACTIONS REQUIRED

### Phase 1: Coefficient Verification (CRITICAL)
1. **Cross-reference official ACC/AHA Risk Estimator Plus source code**
2. **Verify against Goff et al. Circulation 2014 supplementary materials**
3. **Check AHA/ACC Risk Calculator API documentation**
4. **Validate baseline survival probabilities**

### Phase 2: Algorithm Debugging
1. **Test individual coefficient contributions**
2. **Verify natural log transformations**
3. **Check race/sex coefficient selection logic**
4. **Validate Cox proportional hazards formula**

### Phase 3: Reference Validation
1. **Manual calculation verification using published examples**
2. **Cross-validation with multiple online calculators**
3. **Comparison with peer-reviewed validation studies**

## 📚 RESEARCH PRIORITIES

### Official Sources to Verify
1. **Primary**: Goff DC Jr, et al. 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk. Circulation. 2014;129:S49-S73.
2. **Supplementary**: ACC/AHA Risk Estimator Plus technical specifications
3. **Validation**: Yadlowsky S, et al. Clinical Implications of Revised Pooled Cohort Equations. Ann Intern Med. 2018;169:20-29.

### Specific Technical Details Needed
- **Exact coefficient values** from original derivation cohorts
- **Baseline survival probabilities** (S₀₁₀) calculation methodology
- **Mean coefficient values** for risk factor centering
- **Age interaction terms** implementation specifications

## 🔧 DEBUGGING STRATEGY

### Step 1: Coefficient Audit
```javascript
// Compare our coefficients with official sources
const officialCoefficients = {
  // TO BE VERIFIED AGAINST OFFICIAL SOURCES
};
```

### Step 2: Manual Calculation Verification
```javascript
// Test Case 1 manual calculation step-by-step
// Expected: 7.5%, Calculated: 10.0%, Deviation: +2.5%
const manualCalc = {
  // Verify each step against medical literature
};
```

### Step 3: Component Testing
- Test coefficient selection logic
- Validate natural log calculations
- Check baseline survival application
- Verify risk categorization thresholds

## 🚨 PATIENT SAFETY IMPLICATIONS

### Current Status
- **ALGORITHM NOT VALIDATED** - Do not use for clinical decisions
- **Systematic risk overestimation** for African Americans could lead to unnecessary treatment
- **Risk underestimation** for some patients could delay needed therapy

### Required Actions Before Clinical Use
1. **Complete coefficient verification**
2. **Achieve <0.5% deviation** on all test cases
3. **Clinical expert review** by board-certified cardiologist
4. **External validation** against official calculators

## 📋 NEXT STEPS

### Immediate (Today)
1. **Research official coefficient sources**
2. **Cross-validate with ACC/AHA calculator**
3. **Identify specific coefficient discrepancies**

### Short-term (This Week)
1. **Correct coefficient implementation**
2. **Re-run comprehensive test suite**
3. **Achieve validation targets**

### Medium-term (Next Phase)
1. **Clinical expert review**
2. **Production deployment preparation**
3. **Continuous monitoring setup**

## 🎯 SUCCESS CRITERIA

### Validation Targets
- **All test cases must pass** within ±0.5% deviation
- **Risk categories must match** official classifications
- **Cross-validation required** with multiple official sources
- **Clinical review approval** before production use

**STATUS: ALGORITHM REQUIRES IMMEDIATE CORRECTION BEFORE CLINICAL USE** 🚨 